Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Edesa Biotech (EDSA) EPS (Weighted Average and Diluted) (2016)

Edesa Biotech's EPS (Weighted Average and Diluted) history spans 4 years, with the latest figure at -$0.15 for Q3 2016.

  • For Q3 2016, EPS (Weighted Average and Diluted) rose 24.02% year-over-year to -$0.15; the TTM value through Sep 2016 reached -$0.15, up 57.79%, while the annual FY2016 figure was -$0.57, 58.33% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2016 was -$0.15 at Edesa Biotech, down from -$0.14 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.01 in Q1 2015 and bottomed at -$0.2 in Q3 2015.
  • The 4-year median for EPS (Weighted Average and Diluted) is -$0.13 (2015), against an average of -$0.1.
  • The largest annual shift saw EPS (Weighted Average and Diluted) surged 75.0% in 2014 before it fell 7.69% in 2016.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.08 in 2013, then soared by 75.0% to -$0.02 in 2014, then tumbled by 900.0% to -$0.2 in 2015, then rose by 24.02% to -$0.15 in 2016.
  • Per Business Quant, the three most recent readings for EDSA's EPS (Weighted Average and Diluted) are -$0.15 (Q3 2016), -$0.14 (Q2 2016), and -$0.2 (Q3 2015).